June 21, 2021 — The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim's dabigatran etexilate (Pradaxa) anticoagulant oral pellets as the first oral anticoagulant to treat children ...
Deep Vein Thrombosis (DVT)
Deep vein thrombosis (DVT) is caused by the formation of venous blood clots in the arms and legs. This page includes information on technologies to treat DVT using catheter based interventions and thrombolysis.
-
-
Behnood Bikdeli M.D., a cardiologist at the Brigham and Women’s Hospital, Harvard Medical School, Boston, offers an overview of numerous trials in progress testing a variety of anticoagulants and ...
-
October 26, 2020 — The U.S. Food and Drug Administration (FDA) has cleared the Medtronic Abre venous self-expanding stent system. This device is indicated for use in the iliofemoral veins in patients ...
-
September 11, 2020 — The National Institutes of Health (NIH) has launched two of three adaptive clinical trials evaluating the safety and effectiveness of varying types of blood thinners to treat ...
January 10, 2022 – Akura Medical Inc., a Shifamed portfolio company, announced the closing of its $25 million Series A1 ...
January 10, 2022
June 21, 2021 — The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim's dabigatran etexilate ...
June 21, 2021
Behnood Bikdeli M.D., a cardiologist at the Brigham and Women’s Hospital, Harvard Medical School, Boston, offers an ...
April 01, 2021
Feature | Antiplatelet and Anticoagulation Therapies | By Dave Fornell, Editor
A comprehensive review or more than 80 randomized controlled trials (RCTs) investigating how to best manage optimal ...
March 22, 2021
January 8, 2021 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Inari Medical Inc ...
January 08, 2021
December 23, 2020 — Three clinical trial platforms working together to test the effects of full doses of anticoagulants ...
December 23, 2020
October 26, 2020 — The U.S. Food and Drug Administration (FDA) has cleared the Medtronic Abre venous self-expanding ...
October 26, 2020
September 11, 2020 — The National Institutes of Health (NIH) has launched two of three adaptive clinical trials ...
September 11, 2020
May 4, 2020 — A committee comprised of vascular surgeons, medical physicians and technologists from the University of ...
May 04, 2020
December 27, 2019 — The U.S. Food and Drug Administration (FDA) has approved two applications for the first generics of ...
December 27, 2019
November 7, 2019 — The ClotTriever Outcomes (CLOUT) Registry is evaluating real-world patient outcomes following ...
November 14, 2019
May 17, 2019 — The U.S. Food and Drug Administration (FDA) this week approved Fragmin (dalteparin sodium) injection, for ...
May 17, 2019
May 6, 2019 — The U.S Food and Drug Administration (FDA) has cleared the Boston Scientific Vici Venous Stent System for ...
May 06, 2019
February 12, 2019 — A study presented at the 2018 annual meeting of the Cardiovascular and Interventional Radiology ...
February 12, 2019
Feature | Thrombectomy Devices | Dave Fornell, Editor
Catheter-based blood clot removal a decade ago was a standard of care for acute coronary revascularization, but declined ...
January 22, 2019© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now